CVS agrees to $315 million civil settlement over controlled-substance prescriptions
The Justice Department says CVS agreed to pay $315 million to resolve civil allegations involving controlled-substance prescriptions and federal health-program claims.
What the record says
DOJ announcement dated October 13, 2026.
CVS agreed to pay $315 million.
The settlement includes additional controlled-substance dispensing safeguards.
The October 13 announcement says the settlement covers allegations concerning prescriptions filled from October 17, 2013, through December 2, 2025. CVS also entered an agreement with DEA requiring a reporting hotline, proactive monitoring of pharmacy dispensing patterns and a process to evaluate potentially unlawful prescribers.
Source details and supporting locations.
Practical next step
Read DOJ’s announcement and linked agreements for the settlement scope and compliance obligations.
Limits and what is not established
The claims resolved are allegations only, and DOJ expressly says there has been no determination of liability. This is not a criminal conviction or an announcement of direct payments to individual customers.
Sources checked October 14, 2026. Later notices may change instructions or arrangements.
Original sources
U.S. Department of Justice: original information